Join ATMA Co-founders David Harder and Vu Tran for an update on the current road map to get psilocybin and MDMA through clinical trials and on to a designation for therapy use in Canada and the United States. We will also provide information on updates to regulations and legalization in Alberta, Oregon, and Colorado and how they all play out under the context of psilocybin-assisted therapy and MDMA-assisted therapy.
Wherever you practice in North America, if you are interested in psychedelic assisted therapy, you will benefit from the information in this Exposé. You will leave this free session with a better understanding of steps you can take now to start offering psychedelic therapy in the near future.
What you’ll learn:
Join our newsletter for the latest updates, insights, and exclusive offers on everything psychedelic therapy.